🟢 Abivax is trading 4.1% up today despite a weaker broader U.S. market

Abivax is trading 4.1% up now at $119.50, with no clear company-specific catalyst identified.

• No clear company-specific announcement dated September 8, 2026, was identified.
• Recent coverage references positive FDA feedback from July 30, 2026, but it is not a fresh catalyst.
• Approximately 936,523 shares traded by 12:52 p.m. EDT; the broader U.S. market was weaker.